Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
8.47
-0.10 (-1.17%)
Mar 10, 2025, 12:32 PM EST - Market open

Treace Medical Concepts Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Treace Medical Concepts stock have an average target of 9.07, with a low estimate of 7.00 and a high estimate of 14.5. The average target predicts an increase of 7.08% from the current stock price of 8.47.

Analyst Consensus: Hold
Target Low Average Median High
Price $7.00 $9.07 $8.00 $14.5
Change -17.36% +7.08% -5.55% +71.19%

Analyst Ratings

The average analyst rating for Treace Medical Concepts stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 001111
Buy 000000
Hold 667777
Sell 000000
Strong Sell 000000
Total 668888

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Truist Securities
Truist Securities
Hold
Maintains
$8.4$10
Hold Maintains $8.4$10 +18.06% Mar 3, 2025
Lake Street
Lake Street
Strong Buy
Initiates
$15
Strong Buy Initiates $15 +71.19% Dec 31, 2024
Truist Securities
Truist Securities
Hold
Maintains
$7$8.4
Hold Maintains $7$8.4 -0.83% Dec 18, 2024
JP Morgan
JP Morgan
Hold
Initiates
$8
Hold Initiates $8 -5.55% Dec 17, 2024
Stifel
Stifel
Hold
Maintains
$7$8
Hold Maintains $7$8 -5.55% Nov 6, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
230.19M
from 209.36M
Increased by 9.95%
Revenue Next Year
253.57M
from 230.19M
Increased by 10.16%
EPS This Year
-0.76
from -0.90
EPS Next Year
-0.66
from -0.76
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
57.37M94.42M141.84M187.12M209.36M230.19M253.57M264.59M
Revenue Growth
45.54%64.59%50.22%31.92%11.89%9.95%10.16%4.35%
EPS
-0.12-0.43-0.77-0.81-0.90-0.76-0.66-
EPS Growth
--------
Forward PE
--------
No. Analysts -----993
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 240.6M 275.1M 272.4M
Avg 230.2M 253.6M 264.6M
Low 219.1M 234.8M 254.2M

Revenue Growth

Revenue Growth 202520262027
High
14.9%
19.5%
7.4%
Avg
10.0%
10.2%
4.3%
Low
4.7%
2.0%
0.3%

EPS Forecast

EPS 20252026
High -0.70 -0.49
Avg -0.76 -0.66
Low -0.86 -0.74

EPS Growth

EPS Growth 20252026
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.